Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FKZ5VF_UFg-bLYXz4RylY1knhFnk.uncropped.jpg&w=3840&q=75)
Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoChange DetectedThe study has expanded to 65 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.1%
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check18 days agoChange DetectedA new erratum was published in the Lancet on June 16, 2018, regarding the study on dolutegravir-rilpivirine for maintaining virological suppression in adults with HIV-1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6. This change represents an update in the study details and results of the clinical trial evaluating the efficacy, safety, and tolerability of switching to Dolutegravir plus Rilpivirine from current antiretroviral regimens in HIV-1-infected adults.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value Revision: v2.9.3 has recently changed to Revision: v2.9.5. This change represents an update in the study record details and results of the clinical trial involving the switch to Dolutegravir + Rilpivirine from current antiretroviral regimens in HIV-1 infected adults.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value Revision: v2.9.1 has recently changed to Revision: v2.9.3. This change represents an update in the study record details and results of the clinical trial involving the switch to Dolutegravir + Rilpivirine from current antiretroviral regimens in HIV-1 infected adults.SummaryDifference0.0%
Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.